Clinical trial · Interventional
Telepalliation - Digital Platform for Patients in Palliation and Their Relatives
Elepalliation - Digital Platform for Patienter i Palliation og Deres pårørende
NCT04995848CI-TRIAL-00068100unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project has focus on patients in palliation testing a digital platform TelePal.dk.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chronic Obstructive Pulmonary Disease | — | UNRESOLVED | — |
| Heart Failure | — | UNRESOLVED | — |
| Neurological Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Telepalliation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Telepalliation group
- description
- The intervention group will participate in the telepalliation program. The patients will lent a tablet during the RCT study to access the TelePal.dk platform an video consultations. The patients will participate from the time they are referred to palliative care, and are enrolled in the telepalliation program for up to six months or until: 1. They stop being followed by the Palliative Team due to lack of symptoms 2. They are diagnosed with delirium based upon clinical guidelines and the Confusion Assessment Method (CAM). The assessment of delirium will be done by either: * The project nurse or the clinical responsible doctor at the patients' home OR * A district nurse under video supervision by the project nurse or the clinical responsible doctor 3. Death of the patient
- interventionNames
- Other: Telepalliation
- type
- NO_INTERVENTION
- label
- Conventional palliation program
- description
- The control group will follow a conventional palliation program. The patients will participate from the time they are referred to palliative care, and are enrolled in the telepalliation program for up to six months or until: 1. They stop being followed by the Palliative Team due to lack of symptoms 2. They are diagnosed with delirium based upon clinical guidelines and the Confusion Assessment Method (CAM). The assessment of delirium will be done by either: * The project nurse or the clinical responsible doctor at the patients' home OR * A district nurse under video supervision by the project nurse or the clinical responsible doctor 3. Death of the patient
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years * Live in Esbjerg, Varde, Billund, Fanø or Vejen Municipality * Cancer, heart failure, chronic obstructive pulmonary disease (COPD), and motor neuron disease (neurological diseases) referred to the Palliation Team at Southwest Jutland Hospital * Basic computer skills or a relative who has basic computer skills Exclusion Criteria: * Delirium at enrolment based on CAM score * Active psychiatric history (as noted in the medical record) other than depression or anxiety related to the main diagnosis referred to palliative care * Lack of ability to cooperate
References
Publications (2)
- DERIVEDSigaard JVA, Joensen EDR, Birgisdottir UR, Spindler H, Dinesen B. Telepalliation creates a sense of security: A qualitative study of patients with cancer receiving palliative care. Palliat Med. 2026 May;40(5):608-616. doi: 10.1177/02692163251364145. Epub 2025 Oct 7. PMID 41055129
- DERIVEDSigaard JVA, Henneberg NC, Schacksen CS, Kronborg SH, Petrini L, Kidholm K, Birgisdottir UR, Spindler H, Dinesen B. A Digital Platform (Telepalliation) for Patients in Palliative Care and Their Relatives: Protocol for a Multimethod Randomized Controlled Trial. JMIR Res Protoc. 2024 Apr 2;13:e49946. doi: 10.2196/49946. PMID 38564264